SB

Snehalatha Balmuri

Active Director Director DIN 10911073
DIN 10911073 First appointment Jan 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Snehalatha Balmuri

Data last updated:

Snehalatha Balmuri is a Director at Medivour Pharma Private Limited (since 2025). The company operates in Paper.

DIN 10911073
Primary Designation Director
Industry Paper
First Appointment 17 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medivour Pharma Private Limited U21001TS2025PTC193015
Director17 Jan 20252025Active

Board colleagues of Snehalatha Balmuri

NameDINCompanyDesignation
Pavan Kumar Balmoori10911074Medivour Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medivour Pharma Private Limited
Premium access

Shareholding and investment profile for Snehalatha Balmuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Snehalatha Balmuri

Snehalatha Balmuri currently holds 1 directorship: Medivour Pharma Private Limited (Director, since 17 Jan 2025).

Snehalatha Balmuri was first appointed on 17 Jan 2025 as Director at Medivour Pharma Private Limited.

The current boards of Snehalatha Balmuri's companies include Pavan Kumar Balmoori (Medivour Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available